<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01213121</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBH 11-2010-040</org_study_id>
    <nct_id>NCT01213121</nct_id>
  </id_info>
  <brief_title>Neurophysiologic Changes in Patients With Bipolar Depression</brief_title>
  <official_title>Exploring Alterations of Central Autonomic Modulation in Patients With Bipolar Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  To examine differences in neurophysiologic parameters between unmedicated patients with
           bipolar depression and healthy controls

        -  To examine within-subject changes in neurophysiologic parameters in patients with
           bipolar depression treated with quetiapine
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Alterations of neurophysiologic regulation has been suggested in patients with major
           depressive disorder or bipolar disorders

        -  Depressive phase of bipolar disorder shows multi-faceted characteristics different from
           unipolar depression

        -  Quetiapine is an atypical antipsychotic licensed for treatment of bipolar depression

        -  The aim of this study is to investigate the pattern of neurophysiologic dysregulation in
           bipolar depression and its changes induced by quetiapine treatment
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Rate Variability</measure>
    <time_frame>Six weeks</time_frame>
    <description>heart rate variability parameters of time/frequency/complexity domains</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardio-Respiratory Coupling</measure>
    <time_frame>Six weeks</time_frame>
    <description>integrative parameters of interaction between neurocardiac dynamics and respiratory rhythm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electroencephalographic Changes</measure>
    <time_frame>Six weeks</time_frame>
    <description>Electrical brain activities measured by quantitative electroencephalography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of Mood Symptoms</measure>
    <time_frame>Six weeks</time_frame>
    <description>Hamilton Depression Rating Scale
Bipolar Depression Rating Scale
Young Mania Rating Scale
Difficulties in Emotion Regulation Scale
Emotion Regulation Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of Extrapyramidal Symptom Scale</measure>
    <time_frame>Six weeks</time_frame>
    <description>Drug-Induced Extrapyramidal Symptom Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bipolar Depression</condition>
  <arm_group>
    <arm_group_label>bipolar depression</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>unmedicated patients with bipolar depression receiving quetiapine treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>healthy controls matched for age, gender, and body mass index</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Quetiapine</intervention_name>
    <description>oral tablet/25-600mg per day/once a day/six weeks</description>
    <arm_group_label>bipolar depression</arm_group_label>
    <other_name>Seroquel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-IV bipolar disorder I or II

          -  Depressive phase

          -  Drug-naive or drug-free

        Exclusion Criteria:

          -  Serious medical or neurological conditions

          -  DSM-IV substance-related disorders (within 12 months prior to participation)

          -  Mentally retarded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae Seung Chang, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae Seung Chang, M.D., Ph.D.</last_name>
    <phone>82-31-787-7437</phone>
    <email>cjs0107@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ji Sun Kim, M.D.</last_name>
    <phone>82-10-9933-1286</phone>
    <email>ideal91@hanmail.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neuropsychiatry, Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-Si</city>
        <state>Gyeonggi-Do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Seung Chang, M.D., Ph.D.</last_name>
      <phone>82-31-787-7437</phone>
      <email>cjs0107@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Ji Sun Kim, M.D.</last_name>
      <phone>82-10-9933-1286</phone>
      <email>ideal91@hanmail.net</email>
    </contact_backup>
    <investigator>
      <last_name>Ju Young Her, M.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.nimh.nih.gov/trials/bipolar-disorder-manic-depressive-illness.shtml</url>
    <description>Click here for more information about recent updates on bipolar disorder research</description>
  </link>
  <reference>
    <citation>Berger S, Boettger MK, Tancer M, Guinjoan SM, Yeragani VK, Bär KJ. Reduced cardio-respiratory coupling indicates suppression of vagal activity in healthy relatives of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):406-11. doi: 10.1016/j.pnpbp.2010.01.009. Epub 2010 Jan 18.</citation>
    <PMID>20083149</PMID>
  </reference>
  <reference>
    <citation>Bär KJ, Schuhmacher A, Höfels S, Schulz S, Voss A, Yeragani VK, Maier W, Zobel A. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram. J Affect Disord. 2010 Dec;127(1-3):266-73. doi: 10.1016/j.jad.2010.05.010. Epub 2010 Jun 9.</citation>
    <PMID>20538342</PMID>
  </reference>
  <reference>
    <citation>Chang JS, Yoo CS, Yi SH, Hong KH, Oh HS, Hwang JY, Kim SG, Ahn YM, Kim YS. Differential pattern of heart rate variability in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 31;33(6):991-5. doi: 10.1016/j.pnpbp.2009.05.004. Epub 2009 May 7.</citation>
    <PMID>19427888</PMID>
  </reference>
  <reference>
    <citation>Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry. 2010 Jun 1;67(11):1067-74. doi: 10.1016/j.biopsych.2009.12.012. Epub 2010 Feb 6. Review.</citation>
    <PMID>20138254</PMID>
  </reference>
  <reference>
    <citation>Kemp AH, Gray MA, Silberstein RB, Armstrong SM, Nathan PJ. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage. 2004 Jul;22(3):1084-96.</citation>
    <PMID>15219580</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2010</study_first_submitted>
  <study_first_submitted_qc>September 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2010</study_first_posted>
  <last_update_submitted>November 19, 2013</last_update_submitted>
  <last_update_submitted_qc>November 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Jae Seung Chang</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>bipolar depression</keyword>
  <keyword>heart rate variability</keyword>
  <keyword>cardio-respiratory coupling</keyword>
  <keyword>electroencephalography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quetiapine Fumarate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

